If I use Airsupra (albuterol + budesonide) twice daily, do I still need a regular maintenance inhaler?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Airsupra Used Twice Daily: Do You Need Maintenance Therapy?

No, if you are using Airsupra (albuterol-budesonide) twice daily as an as-needed rescue inhaler, you do not automatically need a separate maintenance inhaler—Airsupra is FDA-approved as rescue therapy that can be used with or without maintenance therapy, but it is NOT approved as maintenance therapy itself.

Understanding Airsupra's Role

Airsupra is specifically approved for as-needed (rescue) use only, not for scheduled maintenance dosing 1. The key distinction here is critical:

  • As-needed use: Taking Airsupra when you have symptoms or before exercise
  • Scheduled maintenance: Taking an inhaler at fixed times daily regardless of symptoms

When Maintenance Therapy IS Needed

You need to continue or add maintenance therapy if:

  • You have moderate-to-severe asthma requiring daily controller medications. The pivotal MANDALA trial specifically studied patients with uncontrolled moderate-to-severe asthma who were already on inhaled corticosteroid-containing maintenance therapies 2. In this population, Airsupra reduced severe exacerbations by 26% compared to albuterol alone, but it was used in addition to ongoing maintenance therapy.

  • Your asthma requires daily symptom control. If you're using Airsupra twice daily every single day on a scheduled basis, this suggests your asthma is not well-controlled and you likely need proper maintenance therapy 3.

When Maintenance Therapy May NOT Be Needed

For mild asthma, the recent BATURA trial (2025) demonstrated that as-needed Airsupra alone (without maintenance therapy) reduced severe exacerbations by 47% compared to albuterol alone 4. Importantly:

  • 74.4% of participants used only a SABA at baseline (no maintenance therapy)
  • The mean use was approximately 2.6 inhalations per day 5
  • This represents true as-needed use, not scheduled twice-daily dosing

Critical Pitfall to Avoid

Using Airsupra on a fixed twice-daily schedule is NOT the intended use and does NOT constitute maintenance therapy 1. If you find yourself needing it twice daily every day:

  1. This signals poor asthma control
  2. You should contact your healthcare provider
  3. You likely need to start or optimize true maintenance therapy (daily ICS or ICS-LABA)

The 2020 NAEPP guidelines emphasize that "scheduled, daily ICS treatment is the currently preferred pharmacologic controller therapy for persistent asthma" 3.

The Bottom Line Algorithm

If you have mild asthma with intermittent symptoms:

  • Airsupra as-needed alone may be sufficient 4
  • No separate maintenance inhaler required

If you have moderate-to-severe asthma:

  • Continue your maintenance therapy (ICS or ICS-LABA)
  • Use Airsupra as rescue therapy on top of maintenance 2

If you're using Airsupra twice daily every single day:

  • This is NOT appropriate scheduled maintenance use
  • Reassess with your provider for proper maintenance therapy
  • Airsupra should remain as true rescue therapy only

References

Research

Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.

The New England journal of medicine, 2022

Research

As-Needed Albuterol-Budesonide in Mild Asthma.

The New England journal of medicine, 2025

Research

Albuterol-budesonide rescue inhaler for asthma: Patterns of use and safety in the MANDALA trial.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.